Novavax says Indonesia has given the world’s first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.
Vaccine maker Novavax says its shot is highly effective against COVID-19 and also protects against variants.
In October, it addressed concerns that production of the vaccine had been slowed by a lack of raw materials and other issues, saying it planned to “achieve a capacity of 150 million doses per month by the end of the fourth quarter” through partnerships with Serum Institute of India, SK Bioscience in South Korea and Takeda in Japan, among others.
Indonesia was battered by a deadly wave of COVID-19 fueled by the Delta variant and post-holiday travel from June through August. The number of new cases has now dropped, averaging less than 1,000 a day since mid-October.Why the question of vaccinating younger children against COVID-19 is more complicated than it would initially appear.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Novavax Covid-19 Vaccine Gets First Emergency Authorization In Indonesia—Here’s What You Need To KnowI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Baca lebih lajut »
Novavax COVID-19 vaccine receives first emergency use authorizationNovavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their COVID-19 vaccine in Indonesia, making it the first approval anywhere in the world for Novavax.
Baca lebih lajut »
Indonesia is first country to authorize Novavax Covid-19 vaccineNEW: Novavax says Indonesia has given the world's first emergency use authorization for its Covid-19 vaccine, which uses a different technology than currently used shots.
Baca lebih lajut »
How much is Big Pharma making from COVID-19 vaccines? We're about to find outEarnings Watch: U.S. pharmaceutical companies are expected to collect more revenue from COVID-19 vaccines in the third quarter than they did in the entire first half of the year.
Baca lebih lajut »
Large U.S. companies to be required to provide paid time off for COVID-19 vaccinations, recoveryOSHA's proposed policy will require companies to provide their employees with paid time off to receive a COVID-19 vaccine and recover from vaccine side effects.
Baca lebih lajut »
Russia counts cost of missteps, vaccine refusals as COVID tide keeps risingAmbulance attendant Roman Stebakov has come face-to-face with COVID-19 many times - but he'd rather take his chances with the disease than get himself injected with Russia's Sputnik V vaccine.
Baca lebih lajut »